ABT vs. ABBV
Compare and contrast key facts about Abbott Laboratories (ABT) and AbbVie Inc. (ABBV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ABT or ABBV.
Correlation
The correlation between ABT and ABBV is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
ABT vs. ABBV - Performance Comparison
Key characteristics
ABT:
1.02
ABBV:
0.70
ABT:
1.61
ABBV:
1.04
ABT:
1.20
ABBV:
1.16
ABT:
0.79
ABBV:
0.93
ABT:
4.25
ABBV:
2.19
ABT:
4.74%
ABBV:
8.07%
ABT:
19.66%
ABBV:
25.22%
ABT:
-45.62%
ABBV:
-45.09%
ABT:
-5.91%
ABBV:
-5.29%
Fundamentals
ABT:
$228.81B
ABBV:
$362.98B
ABT:
$7.64
ABBV:
$2.39
ABT:
17.27
ABBV:
85.85
ABT:
4.17
ABBV:
0.43
ABT:
$31.99B
ABBV:
$44.02B
ABT:
$17.78B
ABBV:
$33.24B
ABT:
$8.53B
ABBV:
$12.60B
Returns By Period
The year-to-date returns for both stocks are quite close, with ABT having a 17.25% return and ABBV slightly lower at 16.56%. Over the past 10 years, ABT has underperformed ABBV with an annualized return of 13.24%, while ABBV has yielded a comparatively higher 18.53% annualized return.
ABT
17.25%
-5.91%
17.26%
20.18%
12.70%
13.24%
ABBV
16.56%
-2.97%
6.08%
17.70%
28.24%
18.53%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ABT vs. ABBV — Risk-Adjusted Performance Rank
ABT
ABBV
ABT vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Abbott Laboratories (ABT) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ABT vs. ABBV - Dividend Comparison
ABT's dividend yield for the trailing twelve months is around 1.70%, less than ABBV's 3.07% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABT Abbott Laboratories | 1.70% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% | 1.95% |
ABBV AbbVie Inc. | 3.07% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
Drawdowns
ABT vs. ABBV - Drawdown Comparison
The maximum ABT drawdown since its inception was -45.62%, roughly equal to the maximum ABBV drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for ABT and ABBV. For additional features, visit the drawdowns tool.
Volatility
ABT vs. ABBV - Volatility Comparison
Abbott Laboratories (ABT) has a higher volatility of 7.14% compared to AbbVie Inc. (ABBV) at 6.21%. This indicates that ABT's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ABT vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Abbott Laboratories and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities